Anika Therapeutics Announces Full Market Release Of Integrity Implant System
Anika Therapeutics Announces Full Market Release Of Integrity Implant System
阿尼卡療法宣佈完全上市完整植入系統
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika's proprietary hyaluronic acid (HA) regenerative portfolio
Integrity及其全套關節鏡手術裝置現在在美國全面上市，擴展了Anika專有的透明質酸（HA）再生產品組合
Over 300 surgeries completed during the limited market release, highlighting the growing interest and commercial demand across a wide range of tendon repairs
在有限的市場發佈期間完成了超過300例手術，並突顯出對各種肌腱修復的日益增長的興趣和商業需求。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。